Accumulating evidence suggests that proinflammatory cytokines play an important role in white matter injury in preterm infants, a condition in which oligodendrocyte (OL) progenitor cells are preferentially injured. We investigated the role of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and its death (TRAIL-R1, TRAIL-R2) and decoy (TRAIL-R3, TRAIL-R4) receptors in periventricular white matter injury (PWMI). We hypothesized that the maturation-dependent vulnerability of OLs to TRAIL is due to the differential TRAIL receptor expression. We previously investigated TRAIL/TRAIL receptor expression levels in rat OLs in vivo in the context of PWMI. We found that during different developmental stages, human OLs differentially express TRAIL receptors; and there is a progressive loss of sensitivity to TRAIL as OLs proceed through the maturation process. Our results show that both TRAIL-R1 and -R2 are highly expressed on human OL progenitors and pre-OLs, while TRAIL-R3 and TRAIL-R4 are mainly expressed on immature and mature human OLs. Our results suggest that TRAIL-R1 and TRAIL-R2 might mediate the death signal in human OL precursor cells and pre-OLs.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Jakovcevski I., Filipovic R., Mo Z., Rakic S., Zecevic N. 2009. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front. Neuroanat. 3, 5.
Buchet D., Baron-Van Evercooren A. 2009. In search of human oligodendroglia for myelin repair. Neurosci. Lett. 456, 112–119.
Volpe J.J. 2009. Electroencephalography may provide insight into timing of premature brain injury. Pediatrics. 124, e542–544.
Back S.A. 2006. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment. Retard. Dev. Disabil. Res. Rev. 12, 129–140.
Kaindl A.M., Favrais G., Gressens P. 2009. Molecular mechanisms involved in injury to the preterm brain. J. Child Neurol. 24, 1112–1118.
Jurewicz A., Matysiak M., Andrzejak S., Selmaj K. 2006. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia. 53, 158–166.
Oldenhuis C.N., Stegehuis J.H., Walenkamp A.M., de Jong S., de Vries E.G. 2008. Targeting TRAIL death receptors. Curr. Opin. Pharmacol. 8, 433–439.
Huang Z., Song L., Wang C., Liu J.Q., Chen C. 2011. Hypoxia-ischemia upregulates TRAIL and TRAIL receptors in the immature rat brain. Dev. Neurosci. 33, 519–530.
Hoffmann O., Zipp F., Weber J.R. 2009. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation. J. Mol. Med. (Berlin). 87, 753–763.
Wilson H.C., Onischke C., Raine C.S. 2003. Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors. Glia. 44, 153–165.
Pang Y., Cai Z., Rhodes P.G. 2005. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J. Neurosci. Res. 80, 226–234.
Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184, 39–51.
Walczak H., Degli-Esposti M.A., Johnson R.S., Smolak P.J., Waugh J.Y., Boiani N., Timour M.S., Gerhart M.J., Schooley K.A., Smith C.A., Goodwin R.G., Rauch C.T. 1997. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J. 16, 5386–5397.
Spierings D.C., de Vries E.G., Vellenga E., van den Heuvel F.A., Koornstra J.J., Wesseling J., Hollema H., de Jong S. 2004. Tissue distribution of the death ligand TRAIL and its receptors. J. Histochem. Cytochem. 52, 821–831.
Dorr J., Bechmann I., Waiczies S., Aktas O., Walczak H., Krammer P.H., Nitsch R., Zipp F. 2002. Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J. Neurosci. 22, RC209.
Matysiak M., Jurewicz A., Jaskolski D., Selmaj K. 2002. TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain. 125, 2469–2480.
Aktas O., Schulze-Topphoff U., Zipp F. 2007. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front. Biosci. 12, 2912–2921.
Volpe J.J. 2009. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8, 110–124.
Jakovcevski I., Zecevic N. 2005. Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J. Neurosci. 25, 10064–10073.
Horiuchi M., Itoh A., Pleasure D., Itoh T. 2006. MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells. J. Biol. Chem. 281, 20095–20106.
Bradl M., Lassmann H. 2010. Oligodendrocytes: biology and pathology. Acta Neuropathol. 119, 37–53.
Guicciardi M.E., Gores G.J. 2009. Life and death by death receptors. FASEB J. 23, 1625–1637.
Published in Russianin Molekulyarnaya Biologiya, 2014, Vol. 48, No. 6, pp. 963–969.
The article is published in the original.
About this article
Cite this article
Xiao, M.L., Liu, J.Q. & Chen, C. Effect of tumor necrosis factor-related apoptosis-inducing ligand on developing human oligodendrocytes in culture. Mol Biol 48, 845–851 (2014). https://doi.org/10.1134/S002689331406020X
- TNF-related apoptosis-inducing ligand
- white matter injury